Aetna Inc. (NYSE:AET) – Stock analysts at Cantor Fitzgerald upped their FY2017 earnings estimates for shares of Aetna in a research report issued to clients and investors on Wednesday. Cantor Fitzgerald analyst S. Halper now forecasts that the company will earn $9.75 per share for the year, up from their previous estimate of $9.50. Cantor Fitzgerald has a “Neutral” rating on the stock. Cantor Fitzgerald also issued estimates for Aetna’s FY2018 earnings at $10.00 EPS.
AET has been the subject of several other research reports. Deutsche Bank AG boosted their target price on shares of Aetna from $144.00 to $157.00 and gave the company a “hold” rating in a research note on Thursday, July 13th. Credit Suisse Group reiterated an “outperform” rating and set a $165.00 target price (up previously from $160.00) on shares of Aetna in a research note on Thursday, July 13th. Jefferies Group LLC reiterated a “hold” rating and set a $163.00 target price (up previously from $157.00) on shares of Aetna in a research note on Friday, August 4th. Zacks Investment Research lowered shares of Aetna from a “buy” rating to a “hold” rating in a research note on Monday, October 16th. Finally, Raymond James Financial, Inc. upgraded shares of Aetna from a “market perform” rating to an “outperform” rating in a research note on Friday. Eleven equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Aetna has a consensus rating of “Buy” and a consensus target price of $168.78.
ILLEGAL ACTIVITY WARNING: This news story was reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of international trademark and copyright laws. The legal version of this news story can be read at https://www.com-unik.info/2017/11/04/fy2017-eps-estimates-for-aetna-inc-aet-lifted-by-cantor-fitzgerald.html.
Shares of Aetna (NYSE AET) opened at $176.99 on Thursday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.48 and a current ratio of 0.53. The company has a market cap of $56.19 billion, a price-to-earnings ratio of 16.88, a price-to-earnings-growth ratio of 1.57 and a beta of 0.61.
Aetna (NYSE:AET) last released its earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share for the quarter, beating the consensus estimate of $2.06 by $0.39. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The firm had revenue of $14.99 billion during the quarter, compared to analyst estimates of $15.12 billion. During the same quarter in the previous year, the firm earned $2.07 earnings per share. The firm’s revenue for the quarter was down 5.0% compared to the same quarter last year.
The business also recently announced a quarterly dividend, which was paid on Friday, October 27th. Investors of record on Thursday, October 12th were given a $0.50 dividend. The ex-dividend date was Wednesday, October 11th. This represents a $2.00 dividend on an annualized basis and a yield of 1.13%. Aetna’s dividend payout ratio is presently 37.04%.
In other Aetna news, EVP Margaret M. Mccarthy sold 10,288 shares of the company’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $162.85, for a total value of $1,675,400.80. Following the completion of the sale, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Karen S. Lynch sold 15,271 shares of the company’s stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the completion of the sale, the president now directly owns 64,261 shares of the company’s stock, valued at $10,404,498.51. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Guardian Life Insurance Co. of America lifted its holdings in Aetna by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock valued at $173,000 after acquiring an additional 9 shares during the last quarter. Financial Architects Inc lifted its holdings in Aetna by 1.8% in the 2nd quarter. Financial Architects Inc now owns 1,746 shares of the company’s stock valued at $265,000 after acquiring an additional 31 shares during the last quarter. Wedbush Securities Inc. lifted its holdings in Aetna by 1.4% in the 2nd quarter. Wedbush Securities Inc. now owns 3,779 shares of the company’s stock valued at $574,000 after acquiring an additional 52 shares during the last quarter. Calamos Wealth Management LLC lifted its holdings in Aetna by 0.7% in the 2nd quarter. Calamos Wealth Management LLC now owns 8,919 shares of the company’s stock valued at $1,354,000 after acquiring an additional 65 shares during the last quarter. Finally, HM Payson & Co. lifted its holdings in Aetna by 0.5% in the 1st quarter. HM Payson & Co. now owns 12,861 shares of the company’s stock valued at $1,641,000 after acquiring an additional 69 shares during the last quarter. 89.45% of the stock is owned by institutional investors.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
What are top analysts saying about Aetna Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Aetna Inc. and related companies.